Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20.3M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
3.29M
-
Shares change
-
-311K
-
Total reported value, excl. options
-
$17.3M
-
Value change
-
-$1.7M
-
Put/Call ratio
-
0.06
-
Number of buys
-
11
-
Number of sells
-
-15
-
Price
-
$5.25
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q2 2024
36 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value per share as of Q2 2024.
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.29M shares
of 20.3M outstanding shares and own 16.24% of the company stock.
Largest 10 shareholders include KINGDON CAPITAL MANAGEMENT, L.L.C. (654K shares), PERCEPTIVE ADVISORS LLC (623K shares), VANGUARD GROUP INC (589K shares), Nantahala Capital Management, LLC (478K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (231K shares), ADAR1 Capital Management, LLC (202K shares), GEODE CAPITAL MANAGEMENT, LLC (140K shares), MORGAN STANLEY (94.9K shares), BlackRock Inc. (39.5K shares), and Westside Investment Management, Inc. (38.8K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.